Sleep and Breathing

, Volume 16, Issue 3, pp 677–684

Coexistence of obstructive sleep apnoea and metabolic syndrome is independently associated with left ventricular hypertrophy and diastolic dysfunction

  • Yasuhiro Usui
  • Yoshifumi Takata
  • Yuichi Inoue
  • Katsunori Shimada
  • Hirofumi Tomiyama
  • Yosuke Nishihata
  • Kota Kato
  • Kazuki Shiina
  • Akira Yamashina
Original Article



This study was conducted to investigate the impact of the severity of obstructive sleep apnoea (OSA) and metabolic syndrome (MS) on left ventricular (LV) hypertrophy and LV diastolic function.


Echocardiography for evaluation of LV hypertrophy (defined by relative wall thickness (RWT) and LV mass index (LVMI)) and for diastolic function (defined by the early rapid/atrial filling velocity (E/A ratio)) was performed on 660 OSA patients.


In patients with both MS and severe OSA, LVMI and RWT were significantly higher and the E/A ratios were significantly lower compared to patients with neither MS nor severe OSA. Multivariate analysis after adjustment for other descriptive variables demonstrated that (1) coexistent MS and severe OSA was independently associated with increased LVMI and RWT and (2) severe OSA, MS and coexistence of both disorders were independently associated with a decreased E/A ratio. Significant interaction between MS and severe OSA was not observed with respect to LVMI and RWT, but was observed for the E/A ratio.


Coexistent severe OSA and MS can exacerbate LV concentric hypertrophy. However, not only the coexistence of these two disorders, but also either severe OSA or MS can impair LV diastolic function.


Left ventricular diastolic function Left ventricular hypertrophy Metabolic syndrome Obstructive sleep apnoea 


  1. 1.
    Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12:295–300PubMedCrossRefGoogle Scholar
  2. 2.
    Lakka HM, Laaksonen DE, Laaka TA, Niskanen LK, Kumpsalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle aged men. JAMA 288:2709–2716PubMedCrossRefGoogle Scholar
  3. 3.
    Shahar E, Whitney CW, Redline S, Lee ET, Newman AP, Nieto FJ, O’Conner GT, Boland LL, Schwartz JE, Samet LM (2001) Sleep-disordered breathing and cardiovascular disease cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25PubMedGoogle Scholar
  4. 4.
    Sasanabe R, Banno K, Otake K, Hasegawa R, Usui K, Morita M, Shiomi T (2006) Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res 29:315–322PubMedCrossRefGoogle Scholar
  5. 5.
    Parish JM, Adam T, Facchiano L (2007) Relationship of metabolic syndrome and obstructive sleep apnoea. J Clin Sleep Med 3:467–472PubMedGoogle Scholar
  6. 6.
    Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y, Kuriyama T (2007) Obstructive sleep apnoea syndrome is associated with some components of metabolic syndrome. Chest 131:1387–1392PubMedCrossRefGoogle Scholar
  7. 7.
    Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, Solinas P, Gorini M, Maggioni AP (2001) Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol 38:1829–1835PubMedCrossRefGoogle Scholar
  8. 8.
    Iriarte MM, Perez Olea J, Sagastagoitia D, Sagastagoitia D, Molinero E, Murga N (1995) Congestive heart failure due to hypertensive ventricular diastolic dysfunction. Am J Cardiol 76:43–47CrossRefGoogle Scholar
  9. 9.
    Usui Y, Takata Y, Inoue Y, Tomiyama H, Kurohane S, Hashimura Y, Kato K, Saruhara H, Asano K, Shiina K, Yamashina A (2011) Severe obstructive sleep apnoea impairs left ventricular diastolic function in non-obese men. Sleep Med (in press). PMID: 21377928Google Scholar
  10. 10.
    Arias MA, García-Río F, Alonso-Fernández A, Mediano O, Martí I, Villamor J (2005) Obstructive sleep apnoea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112:375–383PubMedCrossRefGoogle Scholar
  11. 11.
    de las Fuentes L, Brown AL, Mathews SJ, Waggoner AD, Soto PF, Gropler RJ, Davila-Roman VG (2007) Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 28:553–559PubMedCrossRefGoogle Scholar
  12. 12.
    Usui Y, Tomiyama H, Hoshimoto H, Takata Y, Inoue Y, Asano K, Kurohane S, Shiina K, Hirayama Y, Yamashina A (2008) Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among obstructive sleep apnoea patients. J Hypertens 26:117–123PubMedCrossRefGoogle Scholar
  13. 13.
    (1999) Sleep-related breathing disorders in adults: recommendations syndrome definition and measurement techniques in clinical research. The Report of an AASM Task Force. Sleep 22:667–689Google Scholar
  14. 14.
    Grungy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association, National Heart, Lung, and Blood Institute (2004) Definition of metabolic syndrome: report of the National Heart, Lung, Blood Institute/Heart Association conference on scientific issues related to definition. Circulation 109:433–438CrossRefGoogle Scholar
  15. 15.
    Sahn DJ, DeMaria A, Kisslo J (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083PubMedCrossRefGoogle Scholar
  16. 16.
    Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613–618PubMedCrossRefGoogle Scholar
  17. 17.
    Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114:345–352PubMedGoogle Scholar
  18. 18.
    Khouri SJ, Maly GT, Suh DD, Walsh TE (2004) A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 17:290–297PubMedCrossRefGoogle Scholar
  19. 19.
    Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM (2007) Statistics in medicine—reporting of subgroup analyses in clinical trials. N Engl J Med 357:2189–2194PubMedCrossRefGoogle Scholar
  20. 20.
    Ghali JK, Liao Y, Cooper R (1998) Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 31:1635–1640PubMedCrossRefGoogle Scholar
  21. 21.
    Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn F, CHARM Investigators and Committees (2007) Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart 93:59–64PubMedCrossRefGoogle Scholar
  22. 22.
    de Simone G, Devereux RB, Chinali M, Roman MJ, Lee ET, Resnick HE, Howard BV (2009) Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study. Nutr Metab Cardiovasc Dis 19:98–104PubMedCrossRefGoogle Scholar
  23. 23.
    Chami HA, Devereux RB, Gottdiener JS, Mehra R, Roman MJ, Benjamin EJ, Gottlieb DJ (2008) Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study. Circulation 117:2599–2607PubMedCrossRefGoogle Scholar
  24. 24.
    Patel DA, Srinivasan SR, Chen W, Berenson GS (2009) Influence of the metabolic syndrome versus the sum of its individual components on left ventricular geometry in young adults (from the Bogalusa Heart Study). Am J Cardiol 104:69–73PubMedCrossRefGoogle Scholar
  25. 25.
    Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D (1999) Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33:1948–1955PubMedCrossRefGoogle Scholar
  26. 26.
    Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators and Committees (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362:777–781PubMedCrossRefGoogle Scholar
  27. 27.
    García-Río F, Arias MA (2007) Obstructive sleep apnoea and left ventricular systolic and diastolic dysfunction. In: Javaheri S (ed) Sleep medicine clinics; sleep and cardiovascular disease. Elsevier Saunders, Philadelphia, pp 565–574Google Scholar
  28. 28.
    Shiina K, Tomiyama H, Takata Y, Usui Y, Asano K, Hirayama Y, Nakamura T, Yamashina A (2006) Concurrent presence of metabolic syndrome in obstructive sleep apnoea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertens Res 29:433–441PubMedCrossRefGoogle Scholar
  29. 29.
    Tomiyama H, Koji Y, Yambe M, Shiina K, Motobe K, Yamada J, Shindo N, Tanaka N, Chikamori T, Yamashina A (2005) Brachial–ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J 69:815–822PubMedCrossRefGoogle Scholar
  30. 30.
    Shimada K, Fujita M, Tanaka A, Yoshida K, Jisso S, Tanaka H, Yoshikawa J, Kohro T, Hayashi D, Okada Y, Yamazaki T, Nagai R, JCAD investigators (2009) Elevated serum C-reactive protein levels predict cardiovascular events in the Japanese Coronary Artery Disease (JCAD) study. Circ J 73:78–85PubMedCrossRefGoogle Scholar
  31. 31.
    Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Yasuhiro Usui
    • 1
  • Yoshifumi Takata
    • 1
  • Yuichi Inoue
    • 2
  • Katsunori Shimada
    • 3
  • Hirofumi Tomiyama
    • 1
  • Yosuke Nishihata
    • 1
  • Kota Kato
    • 1
  • Kazuki Shiina
    • 1
  • Akira Yamashina
    • 1
  1. 1.Department of CardiologyTokyo Medical UniversityTokyoJapan
  2. 2.Department of SomnologyTokyo Medical UniversityTokyoJapan
  3. 3.Second Department of Hygiene and Public HealthTokyo Women’s Medical UniversityTokyoJapan

Personalised recommendations